Danaher Impairment Charges decreased by 86.1% to $14.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 67.4%, from $43.00M to $14.00M. This is a positive signal — lower values indicate better performance for this metric.
High impairment charges suggest poor capital allocation or a decline in the competitive value of the company's assets.
Impairment charges are non-cash write-downs taken when the carrying value of an asset exceeds its fair market value. Thi...
Common in industries with high intangible asset bases, such as pharma and consumer goods.
cf_impairment_charges| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $19.25M | $19.25M | $19.25M | $19.25M | $0.00 | $0.00 | $222.00M | $43.00M | $15.00M | $432.00M | $101.00M | $14.00M |
| QoQ Change | — | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | -80.6% | -65.1% | >999% | -76.6% | -86.1% |
| YoY Change | — | — | — | — | — | — | — | — | -100.0% | -100.0% | >999% | +123.4% | — | — | -54.5% | -67.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.